Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zarife Sahenk

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Muscle & Nerve|June 15, 2010
Direct immunofluoresence in vasculitic neuropathy: specificity of vascular immune depositsMichael P Collins, Isabel Periquet-Collins, Zarife Sahenk, et al.
Seminars in Pediatric Neurology|December 17, 2008
Hypotonia, weakness, and pontocerebellar hypoplasia in siblingsChang-Yong Tsao, Jerry Mendell, Zarife Sahenk, et al.
Journal of Cachexia, Sarcopenia and Muscle|August 8, 2023
AAV1.NT-3 gene therapy in the SOD1KO mouse model of accelerated sarcopeniaLingying Tong, Burcak Ozes, Kyle Moss, et al.
Journal of the Peripheral Nervous System : JPNS|June 11, 2003
Evidence for impaired axonal regeneration in PMP22 duplication: studies in nerve xenograftsZarife Sahenk, Carmen Serrano-Munuera, Lei Chen, et al.
Journal of Neuromuscular Diseases|October 15, 2019
A Novel De Novo Heterozygous SCN4a Mutation Causing Congenital Myopathy, Myotonia and Multiple Congenital AnomaliesMegan Waldrop, Jakkrit Amornvit, Christopher R Pierson, et al.
Aging|March 10, 2023
AAV1.NT-3 gene therapy prevents age-related sarcopeniaBurcak Ozes, Lingying Tong, Morgan Myers, et al.
International Journal of Molecular Sciences|February 27, 2026
AAVrh74.tMCK.NT-3 Surrogate Gene Therapy in a Mouse Model of CMT2ABurcak Ozes, Lingying Tong, Kyle Moss, et al.
Gene Therapy|March 11, 2018
AAV1.NT-3 gene therapy increases muscle fiber diameter through activation of mTOR pathway and metabolic remodeling in a CMT mouse modelMehmet E Yalvac, Jakkrit Amornvit, Lei Chen, et al.
Brain Communications|November 10, 2021
AAV1.NT-3 gene therapy in a CMT2D model: phenotypic improvements in <i>Gars</i> miceBurcak Ozes, Kyle Moss, Morgan Myers, et al.
Brain Communications|November 15, 2024
AAV1.tMCK.NT-3 gene therapy improves phenotype in <i>Sh3tc2</i> mouse model of Charcot-Marie-Tooth Type 4CBurcak Ozes, Lingying Tong, Kyle Moss, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Muscle & Nerve|June 15, 2010
Direct immunofluoresence in vasculitic neuropathy: specificity of vascular immune depositsMichael P Collins, Isabel Periquet-Collins, Zarife Sahenk, et al.
Seminars in Pediatric Neurology|December 17, 2008
Hypotonia, weakness, and pontocerebellar hypoplasia in siblingsChang-Yong Tsao, Jerry Mendell, Zarife Sahenk, et al.
Journal of Cachexia, Sarcopenia and Muscle|August 8, 2023
AAV1.NT-3 gene therapy in the SOD1KO mouse model of accelerated sarcopeniaLingying Tong, Burcak Ozes, Kyle Moss, et al.
Journal of the Peripheral Nervous System : JPNS|June 11, 2003
Evidence for impaired axonal regeneration in PMP22 duplication: studies in nerve xenograftsZarife Sahenk, Carmen Serrano-Munuera, Lei Chen, et al.
Journal of Neuromuscular Diseases|October 15, 2019
A Novel De Novo Heterozygous SCN4a Mutation Causing Congenital Myopathy, Myotonia and Multiple Congenital AnomaliesMegan Waldrop, Jakkrit Amornvit, Christopher R Pierson, et al.
Aging|March 10, 2023
AAV1.NT-3 gene therapy prevents age-related sarcopeniaBurcak Ozes, Lingying Tong, Morgan Myers, et al.
International Journal of Molecular Sciences|February 27, 2026
AAVrh74.tMCK.NT-3 Surrogate Gene Therapy in a Mouse Model of CMT2ABurcak Ozes, Lingying Tong, Kyle Moss, et al.
Gene Therapy|March 11, 2018
AAV1.NT-3 gene therapy increases muscle fiber diameter through activation of mTOR pathway and metabolic remodeling in a CMT mouse modelMehmet E Yalvac, Jakkrit Amornvit, Lei Chen, et al.
Brain Communications|November 10, 2021
AAV1.NT-3 gene therapy in a CMT2D model: phenotypic improvements in <i>Gars</i> miceBurcak Ozes, Kyle Moss, Morgan Myers, et al.
Brain Communications|November 15, 2024
AAV1.tMCK.NT-3 gene therapy improves phenotype in <i>Sh3tc2</i> mouse model of Charcot-Marie-Tooth Type 4CBurcak Ozes, Lingying Tong, Kyle Moss, et al.
Pageof 8